Doctronic reports that Foundayo, an oral GLP-1 for diabetes, shows promise but lacks long-term safety data beyond 68 weeks; ...

Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; "Ono") announced the presentation of data from the randomized, double-blind, placebo-controlled, Phase 2 ...

The U.S. Food and Drug Administration (FDA) announced a “real-time clinical trials” (RTCT) pilot program to permit agency reviewers to review ...

MDS-UPDRS scores remained stable and durable across overall study population after 150 days of treatment with GT-02287 ...

A research team led by Columbia University has developed an open-source framework designed to streamline and accelerate ...

Clinical trial abstracts posted Thursday ahead of this year’s ASCO meeting gave a peek at anticipated datasets from Merck, ...

ConcertAI ® , the real‑world healthcare intelligence company for those advancing research, treatment, and care in oncology and ...

CMO Barry K. Herman, MD, MMM, will present a poster on Mentavi's clinical validation study, published in The Journal of ...

Managing non-EDC (Electronic Data Capture) data integration in clinical trials is a challenge that holds significant promise. As clinical studies continue to draw on data from wearable devices like ...

Veristat ™, a global clinical research organization (CRO) and consultancy specializing in complex studies, announced the launch of InStat ™ by Veristat. InStat is the clinical research industry’s ...

By Ahmed Aboulenein WASHINGTON, April 28 (Reuters) - The U.S. Food and Drug Administration launched a pilot program on Monday aimed at allowing the agency to monitor clinical trial data in real time, ...

The first experimental use of chemotherapy was conducted in 1942 using nitrogen mustard to treat non-Hodgkin lymphoma, 1,2 marking the beginning of modern chemotherapy development, the transition from ...